Scarica l'app Stockscreener
135.51
2.95%
3.88
Pre-mercato:
127.00
-8.51
-6.28%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché A Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$131.63
Aprire:
$132.7
Volume 24 ore:
2.00M
Relative Volume:
0.92
Capitalizzazione di mercato:
$38.27B
Reddito:
$7.23B
Utile/perdita netta:
$1.41B
Rapporto P/E:
27.22
EPS:
4.979
Flusso di cassa netto:
$1.09B
1 W Prestazione:
+6.65%
1M Prestazione:
+17.88%
6M Prestazione:
-2.03%
1 anno Prestazione:
+14.24%
Intervallo 1D:
$132.70
$138.62
Intervallo di 1 settimana:
$125.57
$138.62
Portata 52W:
$108.35
$160.27
Agilent Technologies Inc Stock (A) Company Profile
Nome
Agilent Technologies Inc
Settore
Industria
Telefono
(408) 345-8886
Indirizzo
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, NTRA
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
135.51 | 37.18B | 7.23B | 1.41B | 1.09B | 4.979 |
TMO
Thermo Fisher Scientific Inc
|
505.75 | 182.91B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
193.21 | 133.68B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
554.94 | 43.32B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
260.74 | 37.23B | 2.50B | -226.32M | 71.51M | -1.6412 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-20 | Iniziato | HSBC Securities | Buy |
| 2026-01-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-12-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-02 | Iniziato | Morgan Stanley | Overweight |
| 2025-10-08 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-10-08 | Aggiornamento | UBS | Neutral → Buy |
| 2025-02-10 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-06-27 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-04-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-11-17 | Downgrade | UBS | Buy → Neutral |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-31 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-05-24 | Reiterato | Barclays | Equal Weight |
| 2023-05-24 | Reiterato | BofA Securities | Buy |
| 2023-05-24 | Reiterato | Citigroup | Neutral |
| 2023-05-24 | Reiterato | Credit Suisse | Outperform |
| 2023-05-24 | Reiterato | Evercore ISI | Outperform |
| 2023-05-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | Reiterato | Robert W. Baird | Outperform |
| 2023-05-24 | Reiterato | SVB Securities | Outperform |
| 2023-05-24 | Reiterato | Stifel | Hold |
| 2023-05-24 | Reiterato | TD Cowen | Outperform |
| 2023-05-24 | Reiterato | Wells Fargo | Overweight |
| 2023-05-11 | Iniziato | Barclays | Equal Weight |
| 2023-01-10 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2022-07-08 | Downgrade | Citigroup | Buy → Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | Reiterato | BofA Securities | Buy |
| 2022-02-23 | Reiterato | Citigroup | Buy |
| 2022-02-23 | Reiterato | Cowen | Outperform |
| 2022-02-23 | Reiterato | Evercore ISI | Outperform |
| 2022-02-23 | Reiterato | Stifel | Hold |
| 2022-02-23 | Reiterato | Wells Fargo | Overweight |
| 2021-11-23 | Reiterato | BofA Securities | Buy |
| 2021-11-23 | Reiterato | Cowen | Outperform |
| 2021-11-23 | Reiterato | Stifel | Hold |
| 2021-03-18 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-02-17 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-25 | Aggiornamento | UBS | Neutral → Buy |
| 2020-11-17 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | Iniziato | Atlantic Equities | Neutral |
| 2020-08-19 | Reiterato | BofA Securities | Neutral |
| 2020-08-19 | Reiterato | Citigroup | Neutral |
| 2020-08-19 | Reiterato | Jefferies | Buy |
| 2020-08-19 | Reiterato | Robert W. Baird | Outperform |
| 2020-08-19 | Reiterato | SVB Leerink | Outperform |
| 2020-08-19 | Reiterato | Stifel | Hold |
| 2020-08-19 | Reiterato | Wells Fargo | Overweight |
| 2020-02-24 | Downgrade | Needham | Buy → Hold |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-11-26 | Reiterato | Needham | Buy |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-10-18 | Downgrade | UBS | Buy → Neutral |
| 2019-07-16 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | Downgrade | Barclays | Overweight → Equal Weight |
Mostra tutto
Agilent Technologies Inc Borsa (A) Ultime notizie
Agilent Technologies, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 1/2 Sh - TradingView
Agilent Technologies Closes $600 Million 4.900% Senior Notes Due 2032 Offering and Registration Rights Agreement - Minichart
The 6495D Triple Quadrupole LC/MS from Agilent Technologies Inc.ultra-low detection limits for de - Ad-hoc-news.de
Agilent Technologies (A) Announces $600 Million Senior Notes Off - GuruFocus
Agilent Technologies, Inc. Actuals & Estimates (EUROTLX:4A) - TradingView
Agilent Sells $600 Million of 4.900% Senior Notes Due 2032 in Private Offering - TradingView
Agilent (NYSE: A) issues $600M 4.900% senior notes maturing in 2032 - Stock Titan
Agilent Technologies, Inc. (NYSE:A) completed the acquisition of Biocare Medical, LLC from an investor group led by Excellere Capital Fund III LP, a fund managed by Excellere Capital Management LLC and GHO Capital Partners LLP. - marketscreener.com
Agilent Technologies earnings outlook steady, shares tracked on NYSE - Ad-hoc-news.de
Agilent (A) Stock Trades Up, Here Is Why - TradingView
Agilent completes $950 million Biocare acquisition - grafa.com
Agilent Completes Acquisition of Biocare Medical - Contract Pharma
Agilent Technologies lifts guidance, shares extend recent NYSE gains - Ad-hoc-news.de
Agilent (A) Finalizes Acquisition of Biocare Medical - GuruFocus
Agilent Completes Biocare Medical Acquisition to Expand Pathology Diagnostics Portfolio - citybiz
Agilent Technologies, Inc. (A) Initiated at Neutral With $150 Price Target by Piper Sandler - Insider Monkey
Agilent Technologies Completes Purchase of Biocare Medical From Excellere-Led Investor Group - marketscreener.com
Agilent completes acquisition of Biocare Medical - Investing.com
Agilent completes acquisition of Biocare Medical By Investing.com - Investing.com Canada
Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies - The Manila Times
A6433334 Bond Price and Chart — FINRA:A6433334 - TradingView
A Look at Agilent Technologies Inc (A) After 3.9% Gain -- GF Val - GuruFocus
Agilent Technologies Inc (A)'s Winning Formula: Financial Metrics and Competitive Strengths - GuruFocus
Agilent Technologies Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Global Laboratory Equipment Services Market Size/Share Worth USD 62.83 Billion by 2035 at a 8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
Is the options market predicting a spike in Agilent Technologies stock? - MSN
Agilent Technologies lifts full-year guidance, shares react to Ignite strategy - Ad-hoc-news.de
How Agilent’s Upgraded Outlook and Cancer Diagnostics Push Could Impact Agilent Technologies (A) Investors - Sahm
Agilent Technologies Inc (A) Institutional Confidence - TradingKey
Form 8K Agilent Technologies For: 23 June By Investing.com - Investing.com Canada
Form 6K Agilent Technologies For: 23 June By Investing.com - Investing.com Canada
Barclays Adjusts Price Target on Agilent Technologies to $150 From $145, Maintains Overweight Rating - Moomoo
Agilent Technologies options draw attention, analysts keep a cautious stance on the shares - AD HOC NEWS
Agilent Technologies Inc (A) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Why Agilent Stock Is Slipping Premarket Today - Stocktwits
The InfinityLab LC Series 1260 Infinity II from Agilent Technologies Inc.mid-range HPLC workhorse - AD HOC NEWS
Is the Options Market Predicting a Spike in Agilent Technologies Stock? - Yahoo Finance
Agilent Technologies, Inc. (A) Stock Analysis: A 26.2% Upside Beckons in the Diagnostics & Research Arena - DirectorsTalk Interviews
Agilent Technologies StockAnalyst views after recent earnings beat - AD HOC NEWS
Agilent Technologies (A) Stock Could Be 23% Undervalued After Earnings Beat And Guidance Raise - Yahoo Finance
How Investors May Respond To Agilent Technologies (A) Upgraded Outlook And Push Into AI-Powered Diagnostics - Yahoo Finance
Agilent (A) Opens China Innovation Center And Buys Biocare For Cancer Diagnostics - Yahoo Finance
Research Tools & Consumables Stocks Q1 Results: Benchmarking Agilent (NYSE:A) - Yahoo Finance
Agilent Technologies (A) Stock Could Be 21.1% Undervalued After Earnings Beat And Higher Outlook - Sahm
A News | AGILENT TECHNOLOGIES INC (NYSE:A) - ChartMill
Agilent Technologies Inc. stock outperforms competitors on strong trading day - MarketWatch
AAgilent Technologies Inc Stock Price and Quote - Finviz
Agilent Technologies Inc (A) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Agilent Technologies Inc (A) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Agilent Technologies Inc (A) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Agilent Technologies (A) Short Interest & Short Float | Updated Jun 2026 $A - MarketBeat
Agilent Technologies Inc Azioni (A) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.30%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):